Ilhan Ece1, Huseyin Yilmaz2, Husnu Alptekin2, Serdar Yormaz2, Bayram Colak2, Farise Yilmaz3, Mustafa Sahin2. 1. Department of Surgery, Faculty of Medicine, Selcuk University, 42075, Konya, Turkey. ilhanece@yahoo.com. 2. Department of Surgery, Faculty of Medicine, Selcuk University, 42075, Konya, Turkey. 3. Department of Nuclear Medicine, Faculty of Medicine, Selcuk University, 42075, Konya, Turkey.
Abstract
BACKGROUNDS: The management of super-super obese patients is challenging for bariatric surgeons. Laparoscopic sleeve gastrectomy (LSG) is feasible as two-stage treatment for high-risk patients. However, its efficacy as a stand-alone procedure in super-super obese (SSO) patients is controversial. The study objective was to demonstrate the safety and efficacy of LSG in super-obese (SO) and SSO patients. METHODS: A retrospective analysis was performed of consecutive patients undergoing LSG. The patients were classified into three groups: morbidly obese (MO), SO, and SSO. The patients' data, including each patient's characteristics, body mass index (BMI), preoperative comorbidities, postoperative complications, the resolution of comorbidities, percentage of excess weight loss (%EWL), and total weight loss (%TWL) were compared between groups. RESULTS: Of the 186 patients, 163 (87.6%) were followed up for 41.2 ± 7.3 months (range 33-54 months). The mean BMI was 52.6 kg/m2. Eighty-three patients (50.9%) were MO, 52 (31.9%) were SO, and 28 (17.2%) were SSO. The groups were similar in terms of preoperative characteristics and postoperative complications. The mean %TWL were lower for the SSO group with no significant difference. The mean %TWL at 12, 24, 36, and 41.2 months postoperatively was 34.7, 34.4, 31.4, and 29.6% in SSO group, respectively. Also, the %EWL for the SSO group was significantly lower (48.3%) at the end of the follow-up period. However, the rate of significant improvement or complete resolution of comorbidities was similar in all groups. CONCLUSION: Although %EWL was lower in the SSO group, LSG was a feasible and safe stand-alone bariatric surgical procedure for the resolution of comorbidities in MO, SO, and SSO patients.
BACKGROUNDS: The management of super-super obesepatients is challenging for bariatric surgeons. Laparoscopic sleeve gastrectomy (LSG) is feasible as two-stage treatment for high-risk patients. However, its efficacy as a stand-alone procedure in super-super obese (SSO) patients is controversial. The study objective was to demonstrate the safety and efficacy of LSG in super-obese (SO) and SSO patients. METHODS: A retrospective analysis was performed of consecutive patients undergoing LSG. The patients were classified into three groups: morbidly obese (MO), SO, and SSO. The patients' data, including each patient's characteristics, body mass index (BMI), preoperative comorbidities, postoperative complications, the resolution of comorbidities, percentage of excess weight loss (%EWL), and total weight loss (%TWL) were compared between groups. RESULTS: Of the 186 patients, 163 (87.6%) were followed up for 41.2 ± 7.3 months (range 33-54 months). The mean BMI was 52.6 kg/m2. Eighty-three patients (50.9%) were MO, 52 (31.9%) were SO, and 28 (17.2%) were SSO. The groups were similar in terms of preoperative characteristics and postoperative complications. The mean %TWL were lower for the SSO group with no significant difference. The mean %TWL at 12, 24, 36, and 41.2 months postoperatively was 34.7, 34.4, 31.4, and 29.6% in SSO group, respectively. Also, the %EWL for the SSO group was significantly lower (48.3%) at the end of the follow-up period. However, the rate of significant improvement or complete resolution of comorbidities was similar in all groups. CONCLUSION: Although %EWL was lower in the SSO group, LSG was a feasible and safe stand-alone bariatric surgical procedure for the resolution of comorbidities in MO, SO, and SSO patients.
Authors: G Nosso; E Griffo; M Cotugno; G Saldalamacchia; R Lupoli; G Pacini; G Riccardi; L Angrisani; B Capaldo Journal: Horm Metab Res Date: 2016-01-20 Impact factor: 2.936
Authors: Nicolas V Christou; John S Sampalis; Moishe Liberman; Didier Look; Stephane Auger; Alexander P H McLean; Lloyd D MacLean Journal: Ann Surg Date: 2004-09 Impact factor: 12.969
Authors: Sanoop Koshy Zachariah; Po-Chih Chang; Andrea Se En Ooi; Ming-Che Hsin; Jason Yiu Kin Wat; Chih Kun Huang Journal: Obes Surg Date: 2013-07 Impact factor: 4.129
Authors: Adam C Celio; Qiang Wu; Kevin R Kasten; Mark L Manwaring; Walter J Pories; Konstantinos Spaniolas Journal: Surg Endosc Date: 2016-06-10 Impact factor: 4.584
Authors: Aurora Gil-Rendo; José Ramón Muñoz-Rodríguez; Francisco Domper Bardají; Bruno Menchén Trujillo; Fernando Martínez-de Paz; María Del Prado Caro González; Irene Arjona Medina; Jesús Martín Fernández Journal: Obes Surg Date: 2019-11 Impact factor: 4.129
Authors: Michelle M C Tan; Xingzhong Jin; Craig Taylor; Adrian K Low; Philip Le Page; David Martin; Ang Li; David Joseph; Nic Kormas Journal: J Clin Med Date: 2022-07-31 Impact factor: 4.964